Berberine and inflammatory bowel disease: A concise review.

Area of Science:

• Pharmacology
• Gastroenterology
• Natural Products

Background:

• Berberine, a natural compound from medicinal plants, has a long history in traditional medicine.
• Recent research highlights its diverse pharmacological activities, sparking interest in its therapeutic applications.
• Inflammatory bowel diseases (IBD) lack comprehensive reviews on berberine's efficacy.

Purpose of the Study:

• To review and present up-to-date literature data on berberine's therapeutic potential for IBD.
• To consolidate in vitro and in vivo findings regarding berberine's anti-IBD effects.
• To discuss specific mechanisms beyond general anti-inflammatory and antioxidant properties.

Main Methods:

• Literature search and critical analysis of in vitro and in vivo experimental data.
• Focus on studies investigating berberine's effects on IBD pathogenesis.
• Synthesis of findings related to gut epithelial barrier, T cells, and other relevant pathways.

Main Results:

• Berberine exhibits general antioxidant and anti-inflammatory effects relevant to IBD.
• Specific findings demonstrate berberine's positive impact on gut epithelial barrier pathology.
• Emerging evidence suggests berberine targets T cells and possesses antinociceptive properties beneficial for IBD.

Conclusions:

• Berberine demonstrates significant therapeutic potential for managing inflammatory bowel diseases.
• Its multifaceted actions, including gut barrier protection and immune modulation, support its use.
• Further research is warranted to fully elucidate and translate these findings into clinical practice.